Thanks for your feedback, this will help us improve our content for you!
Share this video
Thank for your feedback, this will help us improve our content for you!
ELCC 2016 | ASSESS trial: Blood test for EGFR mutation in advanced non-small cell lung cancer
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Martin Reck, MD, PhD, from LungenClinic Grosshansdorf, Grosshansdorf, Germany, discusses ASSESS, a trial of the utility of circulating-free tumor DNA in the plasma for the detection of epidermal growth factor receptor (EGFR) mutation status in patients with advanced non-small cell lung cancer.